{'fraction_non_alphanumeric': 0.02122641509433962, 'fraction_numerical': 0.0, 'mean_word_length': 4.666666666666667, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[The drug treatment for bone resorption in the oral area].

The bone resorption in the oral area can be divided into the inflammatory and the metabolic bone resorption. In this review, we show a possibility for drug treatment in oral area, focusing on the drug development of TNF antagonist which inhibits the actions of both TNF-alpha and RANKL; the cytokines which have a critical role in the inflammatory bone resorption.